SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines]